Unleashing the value of point-of-care cell and gene therapies requires a diverse set of scientific, clinical and engineering expertise.
We’ve assembled a team of innovators and executive leaders with decades of experience developing and bringing to market advanced cell and gene therapies using integrated combination device systems.
Each member of our team has played a crucial role in developing peripheral blood collection & processing technology and immunology & oncology cell therapies over the last three decades.
